0 Membri şi 5 Vizitatori vizualizează acest subiect.
[...]Sweden has reported 1,400 Covid deaths in the past month compared with about 100 in Norway and 80 in Finland, each of which have half its population.[...] The region of Stockholm on Wednesday warned that 99 per cent of its intensive care beds were full, while healthcare unions have warned of large numbers of workers quitting as infections, hospitalisations and deaths continue to rise. About 3,600 health personnel have quit in the Stockholm region since the start of the pandemic, according to state broadcaster SVT, around 900 more than over the same period last year.[...] Johanna Sandwall, preparedness director at Sweden’s National Board of Health and Welfare, said on Sunday that Sweden had no plans to seek help from its neighbours yet. “The situation in healthcare is very strained in several parts of the country but we have a nationally available capacity to meet the need right now,” she said.Irene Nilsson Carlsson, senior public health adviser at the board, told the Financial Times: “We are worried about the situation but not that it will run out of control. There are tensions in the intensive care units, a heavy workload for staff. But we can expand the capacity beyond what we have at the moment. So it’s not an acute crisis.”
Citat din: ntire2000 din 24.Nov.2020, 11:35:05 p.m.Pentru urmatoarele 10 milioane cred ca va fi suficienta o saptamâna....Inca 6 milioane în zece zile.
Pentru urmatoarele 10 milioane cred ca va fi suficienta o saptamâna....
[...]As Hotez explained to me, the major reason this vaccine timeline has shrunk is that much of the research and preclinical animal testing was done in the aftermath of the 2003 SARS pandemic (that is, for instance, how we knew to target the spike protein). This would be the model. Scientists have a very clear sense of which virus families have pandemic potential, and given the resemblance of those viruses, can develop not only vaccines for all of them but also ones that could easily be tweaked to respond to new variants within those families.“We do this every year for influenza,” Rasmussen says. “We don’t know which influenza viruses are going to be circulating, so we make our best guess. And then we formulate that into a vaccine using essentially the same technology platform that all the other influenza vaccines are based on.” The whole process takes a few months, and utilizes a “platform” that we already know is basically safe. With enough funding, you could do the same for viral pandemics, and indeed conduct Phase I trials for the entire set of possible future outbreaks before any of them made themselves known to the public. In the case of a pandemic produced by a new strain in these families, you might want to do some limited additional safety testing, but because the most consequential adverse effects take place in the days right after the vaccine is given, that additional diligence could be almost immediate.
Autor
Subiect: Despre Coronavirus (Citit de 164039 ori)
